Day One Biopharmaceuticals

DAWN

Market cap $2.22B

21.47 USD

-0.01

0.05%

At close Updated Apr 10, 4:00 PM EDT

Pre-market

After hours

21.52

+0.05

0.23%

1 day

-0.05%

5 days

0.09%

1 month

0.89%

3 months

89.5%

6 months

196.55%

Year to date

142.6%

1 year

217.6%

5 years

-17.07%

10 years

-17.07%

About: Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Employees: 178

Healthcare Biotechnology